American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2007 | 1.16 Million USD | -30.34% |
| 2006 | 1.67 Million USD | 1.4% |
| 2005 | 1.64 Million USD | -7.77% |
| 2004 | 1.78 Million USD | -54.57% |
| 2003 | 3.93 Million USD | -43.94% |
| 2002 | 7.01 Million USD | 78.2% |
| 2001 | 3.93 Million USD | -70.66% |
| 2000 | 13.42 Million USD | 11769.22% |
| 1999 | 113.07 Thousand USD | -97.06% |
| 1998 | 3.84 Million USD | 24.13% |
| 1997 | 3.09 Million USD | 3.03% |
| 1996 | 3 Million USD | 100.27% |
| 1995 | 1.5 Million USD | -66.67% |
| 1994 | 4.5 Million USD | -36.62% |
| 1993 | 7.1 Million USD | -52.35% |
| 1992 | 14.9 Million USD | 2383.33% |
| 1991 | 600 Thousand USD | -53.85% |
| 1990 | 1.3 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2008 Q3 | 89.77 Thousand USD | 65.29% |
| 2008 Q2 | 54.31 Thousand USD | -71.54% |
| 2008 Q1 | 190.85 Thousand USD | 32.18% |
| 2007 Q2 | 198.17 Thousand USD | -25.43% |
| 2007 Q1 | 265.75 Thousand USD | 7.3% |
| 2007 FY | 1.16 Million USD | -30.34% |
| 2007 Q4 | 144.39 Thousand USD | -74.03% |
| 2007 Q3 | 555.9 Thousand USD | 180.51% |
| 2006 Q3 | 226.75 Thousand USD | -18.5% |
| 2006 FY | 1.67 Million USD | 1.4% |
| 2006 Q1 | 918.57 Thousand USD | 35.47% |
| 2006 Q2 | 278.23 Thousand USD | -69.71% |
| 2006 Q4 | 247.66 Thousand USD | 9.22% |
| 2005 FY | 1.64 Million USD | -7.77% |
| 2005 Q1 | 269.93 Thousand USD | -53.41% |
| 2005 Q2 | 275.64 Thousand USD | 2.12% |
| 2005 Q3 | 381.16 Thousand USD | 38.28% |
| 2005 Q4 | 678.04 Thousand USD | 77.89% |
| 2004 Q3 | 239.34 Thousand USD | -28.92% |
| 2004 Q2 | 336.74 Thousand USD | -46.68% |
| 2004 Q4 | 579.31 Thousand USD | 142.05% |
| 2004 FY | 1.78 Million USD | -54.57% |
| 2004 Q1 | 631.54 Thousand USD | -74.24% |
| 2003 Q3 | 18.68 Thousand USD | -97.83% |
| 2003 FY | 3.93 Million USD | -43.94% |
| 2003 Q1 | 602.37 Thousand USD | -79.4% |
| 2003 Q2 | 861.15 Thousand USD | 42.96% |
| 2003 Q4 | 2.45 Million USD | 13022.93% |
| 2002 Q2 | 2.54 Million USD | 240.77% |
| 2002 Q3 | 798.34 Thousand USD | -68.66% |
| 2002 Q4 | 2.92 Million USD | 266.2% |
| 2002 FY | 7.01 Million USD | 78.2% |
| 2002 Q1 | 747.56 Thousand USD | -63.9% |
| 2001 Q1 | 142.71 Thousand USD | -98.88% |
| 2001 Q3 | 1.24 Million USD | 61.27% |
| 2001 FY | 3.93 Million USD | -70.66% |
| 2001 Q2 | 769.05 Thousand USD | 438.88% |
| 2001 Q4 | 2.07 Million USD | 66.98% |
| 2000 Q3 | 11.91 Thousand USD | -95.65% |
| 2000 FY | 13.42 Million USD | 11769.22% |
| 2000 Q4 | 12.71 Million USD | 106570.88% |
| 2000 Q2 | 274.05 Thousand USD | -72.42% |
| 2000 Q1 | 993.7 Thousand USD | 5400.12% |
| 1999 Q4 | 18.06 Thousand USD | -96.47% |
| 1999 Q1 | 382.42 Thousand USD | -74.54% |
| 1999 Q2 | 796.67 Thousand USD | 108.32% |
| 1999 Q3 | 512.2 Thousand USD | -35.71% |
| 1999 FY | 113.07 Thousand USD | -97.06% |
| 1998 Q4 | 1.5 Million USD | 157.56% |
| 1998 FY | 3.84 Million USD | 24.13% |
| 1998 Q2 | 963.47 Thousand USD | 38.01% |
| 1998 Q3 | 583.07 Thousand USD | -39.48% |
| 1998 Q1 | 698.11 Thousand USD | -36.51% |
| 1997 Q1 | 891.48 Thousand USD | -16.28% |
| 1997 FY | 3.09 Million USD | 3.03% |
| 1997 Q4 | 1.09 Million USD | 621.07% |
| 1997 Q3 | 152.49 Thousand USD | -83.97% |
| 1997 Q2 | 951.51 Thousand USD | 6.73% |
| 1996 Q4 | 1.06 Million USD | 47.08% |
| 1996 FY | 3 Million USD | 100.27% |
| 1996 Q3 | 724.01 Thousand USD | 0.56% |
| 1996 Q1 | 400 Thousand USD | -42.86% |
| 1996 Q2 | 719.99 Thousand USD | 80.0% |
| 1995 Q4 | 700 Thousand USD | -22.22% |
| 1995 FY | 1.5 Million USD | -66.67% |
| 1995 Q3 | 900 Thousand USD | 350.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | -94.44% |
| 1994 FY | 4.5 Million USD | -36.62% |
| 1994 Q2 | 500 Thousand USD | 25.0% |
| 1994 Q4 | 1.8 Million USD | 0.0% |
| 1994 Q3 | 1.8 Million USD | 260.0% |
| 1994 Q1 | 400 Thousand USD | -88.89% |
| 1993 Q2 | 1.2 Million USD | 71.43% |
| 1993 Q1 | 700 Thousand USD | -86.27% |
| 1993 FY | 7.1 Million USD | -52.35% |
| 1993 Q4 | 3.6 Million USD | 111.76% |
| 1993 Q3 | 1.7 Million USD | 41.67% |
| 1992 FY | 14.9 Million USD | 2383.33% |
| 1992 Q2 | 3.2 Million USD | 23.08% |
| 1992 Q3 | 4 Million USD | 25.0% |
| 1992 Q1 | 2.6 Million USD | 186.67% |
| 1992 Q4 | 5.1 Million USD | 27.5% |
| 1991 Q3 | 1 Million USD | -28.57% |
| 1991 Q4 | -3 Million USD | -400.0% |
| 1991 Q1 | 1.3 Million USD | 115.85% |
| 1991 Q2 | 1.4 Million USD | 7.69% |
| 1991 FY | 600 Thousand USD | -53.85% |
| 1990 Q4 | -8.2 Million USD | -356.25% |
| 1990 FY | 1.3 Million USD | 0.0% |
| 1990 Q1 | 3.2 Million USD | 0.0% |
| 1990 Q2 | 3.2 Million USD | 0.0% |
| 1990 Q3 | 3.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ansell Limited | 129.3 Million USD | 99.1% |
| Ansell Limited | 129.3 Million USD | 99.1% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 96.261% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 172.96% |
| Psykey, Inc. | -797.5 Thousand USD | 245.983% |
| ConvaTec Group Plc | 262.7 Million USD | 99.557% |
| ConvaTec Group Plc | 262.7 Million USD | 99.557% |
| Encision Inc. | -640.78 Thousand USD | 281.687% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 920.972% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 1159.056% |
| Innovative MedTech Inc. | -4.27 Million USD | 127.239% |
| LifePoint, Inc. | -7.49 Million USD | 115.533% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 117.966% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -252.794% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 1047.368% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 349.149% |
| SmileDirectClub, Inc. | -241.15 Million USD | 100.483% |
| Sector 10, Inc. | -39.84 Thousand USD | 3021.946% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 99.636% |
| SheerVision, Inc. | 155.72 Thousand USD | -647.608% |
| United Health Products, Inc. | -2.42 Million USD | 147.979% |
| Vasamed, Inc. | 4.74 Million USD | 75.45% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 150.748% |
| Yubo International Biotech Limited | -1.2 Million USD | 196.598% |